{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {},
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Alpha-synuclein oligomers: a new hope ",
      "version": "1.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/hgnc-symbols.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns"
    },
    "path": "snca/bengoa2017.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Over the past two decades, the pre-synaptic protein alphasynuclein (a-syn) has been irrefutably tied to the neurodegenerative disorder Parkinson’s disease.",
      "key": "c3f6620b689b388e5576e7a30070fe12",
      "line": 38,
      "relation": "association",
      "source": 33,
      "target": 47
    },
    {
      "key": "efd324f88a6ed0943388152f284de3b0",
      "relation": "hasVariant",
      "source": 33,
      "target": 36
    },
    {
      "key": "0e3135661aadd1a85c7365c61910052f",
      "relation": "hasVariant",
      "source": 33,
      "target": 34
    },
    {
      "key": "6c0ec01b9033108d41eb40bc01afd6a4",
      "relation": "hasVariant",
      "source": 33,
      "target": 37
    },
    {
      "key": "6fdf5d3df92c3fa728a3f8e6d387b6c0",
      "relation": "hasVariant",
      "source": 33,
      "target": 39
    },
    {
      "key": "bf658431f7a210ffc3c7797008e85de9",
      "relation": "hasVariant",
      "source": 33,
      "target": 38
    },
    {
      "key": "4c99e7547174f2c0b315be0e383852e1",
      "relation": "hasVariant",
      "source": 33,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Over the past two decades, the pre-synaptic protein alphasynuclein (a-syn) has been irrefutably tied to the neurodegenerative disorder Parkinson’s disease.",
      "key": "806ed73a254de5ca7f6ca2902b9ba68c",
      "line": 38,
      "relation": "association",
      "source": 47,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Elevated levels of a-syn oligomers were found in PD patients compared to controls or AD patients in brain homogenate, CSF and serum.",
      "key": "82799c539fcc4a1297a1646da6692c02",
      "line": 194,
      "relation": "positiveCorrelation",
      "source": 47,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "b1257e5dee48f99c87a9eac414da2872",
      "line": 44,
      "relation": "increases",
      "source": 36,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "692c0b4ca0a0d98bc521706332bdbf34",
      "line": 45,
      "relation": "increases",
      "source": 34,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "29d9215258e632a1e4282082198c44ca",
      "line": 46,
      "relation": "increases",
      "source": 34,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "f13ce9d871e87e69d39d2eddbc32d282",
      "line": 47,
      "relation": "increases",
      "source": 37,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "9a33df728defa5747dc9908ae3d11105",
      "line": 49,
      "relation": "increases",
      "source": 39,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "aa84de708db1d8dbb694f2731a4e826d",
      "line": 51,
      "relation": "increases",
      "source": 38,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "the point mutation in SNCA (A53T) was demonstrated to cause autosomal dominant Parkinson’s disease [126] and several other point mutations (A30P, E46K, H50Q, G51D and A53E) have since been shown to cause familial forms of Parkinson’s disease and dementia with Lewy bodies (DLB) [4, 79, 84, 119, 129, 167].",
      "key": "18a5c2f7339acad9b0042ab50957068d",
      "line": 53,
      "relation": "increases",
      "source": 35,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Not only did this discovery draw attention to aggregated forms of a-syn as mediators of Parkinson’s disease pathogenesis, but also opened the door to the use of a-syn detection techniques for diagnosis and staging.",
      "key": "6af2bd72e161c26be9dce0a8a7e81655",
      "line": 59,
      "relation": "increases",
      "source": 5,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": ". Multiple lines of evidence now suggest that oligomeric species of a-syn, which are thought to precede the fibrillar aggregates found in Lewy bodies, are the culprits for neuronal degeneration in Parkinson’s disease",
      "key": "4d4afed2cf51375e598cad9071bce9fb",
      "line": 64,
      "relation": "increases",
      "source": 9,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " Oligomeric detection may have uses as a diagnostic biomarker, as a biomarker of the progression of the disease, and in the future, perhaps as an index of response to novel therapies. ",
      "key": "6fade06bde2b7d84baeb974d1781adf5",
      "line": 189,
      "relation": "biomarkerFor",
      "source": 9,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Elevated levels of a-syn oligomers were found in PD patients compared to controls or AD patients in brain homogenate, CSF and serum.",
      "key": "623a41fc96d5ceca6ae70f0c26bb3c77",
      "line": 194,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": ". Multiple lines of evidence now suggest that oligomeric species of a-syn, which are thought to precede the fibrillar aggregates found in Lewy bodies, are the culprits for neuronal degeneration in Parkinson’s disease",
      "key": "6548be2fdf2bc57be73cde9d13114161",
      "line": 65,
      "relation": "increases",
      "source": 9,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " In vitro formed a-syn oligomers ectopically applied to cell cultures or formed due to overexpression of a-syn induce cell death [20, 30, 109, 149], which has been recapitulated in vivo in several studies.",
      "key": "f4feeeae892911a52b307f2e56e8efd3",
      "line": 76,
      "relation": "increases",
      "source": 9,
      "target": 17
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " In contrast, a-syn 30–110 that forms fibrils at a fast rate, did not display toxicity, indicating that oligomers are indeed the toxic species leading to TH-neuron loss in vivo [162].",
      "key": "f7dfc4c3b4aa7c1ff9fc117319a4f7c2",
      "line": 82,
      "relation": "increases",
      "source": 9,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "In 2014 Plotegher et al. showed that mitochondrial morphology is disrupted by a-syn oligomers, which cause fragmentation of these organelles in vitro in SH-SY5Y cells [124]. ",
      "key": "51d5dfd9775e7afa814a5362e0b2e0f2",
      "line": 89,
      "relation": "decreases",
      "source": 9,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "All these results show that a-syn oligomers are implicated in mitochondrial dysfunction across different models.",
      "key": "50fb645c3e5b912ab71d8c5ce75bbff8",
      "line": 98,
      "relation": "increases",
      "source": 9,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Accumulation of oligomers has been demonstrated in a transgenic mouse overexpressing A53T a-syn and in Parkinson’s disease brain tissue, resulting in chronic ER stress and impaired ER protein quality control [25].",
      "key": "6a6a085240d4c4358b01b30a9fe31a5a",
      "line": 103,
      "relation": "increases",
      "source": 9,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " This can be inhibited by a-syn oligomers: oligomers were shown to inhibit proteasomal activity, which was blocked by addition of antibodies that neutralized the interaction [87]. ",
      "key": "12b0a4ed12424dd470a74023a8dbac4b",
      "line": 114,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 9,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " However, in a different report, oligomers were shown to activate proinflammatory signals in microglial cells in vitro and in vivo, and this was prevented by addition of a MAP kinase inhibitor [161].",
      "key": "8f4fe02368990c9ccba6ae4435c90ea8",
      "line": 131,
      "relation": "increases",
      "source": 9,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " Kim et al. demonstrated that a-syn oligomers lead to microglial inflammatory responses via TLR2 activation [74].",
      "key": "e52d82def603a19bf916a1bb26dbb1ce",
      "line": 136,
      "relation": "increases",
      "source": 9,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " Kim et al. demonstrated that a-syn oligomers lead to microglial inflammatory responses via TLR2 activation [74].",
      "key": "13bb899e8a29fc6797526f28380c4695",
      "line": 137,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 9,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " Another report by Zhang and collaborators also highlighted glial activation and production of reactive oxygen species in response to oligomer-like preparations of aggregated a-syn [168]. ",
      "key": "9dac4308073e26160b49af210975ae39",
      "line": 142,
      "relation": "increases",
      "source": 9,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "A-syn oligomers can stabilize membrane defects accelerating membrane damage [19] and can alter membrane properties such as input resistance reducing neuronal excitability [72]",
      "key": "38baa5cedcbd96cc0c4bf412b344dd18",
      "line": 147,
      "relation": "decreases",
      "source": 9,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Dysfunctional membranes can also have an important impact on calcium homeostasis; some types of oligomers can lead to a cytotoxic calcium influx presumably by building pore-like structures [30]. ",
      "key": "be655e4c5ac49fc471d7c64ece125b9f",
      "line": 152,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular space",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular part",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 9,
      "target": 1
    },
    {
      "key": "4f7587cc1df472556804c3cba93f6747",
      "relation": "partOf",
      "source": 9,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "key": "739aca7cb7a1a03a8c610b4304b1c791",
      "line": 173,
      "relation": "decreases",
      "source": 9,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "key": "07ec04bcd8c35d793e9e9db4b8ed2abf",
      "line": 174,
      "relation": "decreases",
      "source": 9,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "The trafficking of synaptic vesicles may also be negatively impacted by a-syn oligomers, which have been shown to decrease axonal transport by decreasing microtubule stability and impairing the interaction between kinesin and microtubules [128], as well as inhibiting tubulin polymerisation [20]. ",
      "key": "507bab91ed68811c3c5edf80a261ce50",
      "line": 175,
      "relation": "decreases",
      "source": 9,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Golgi fragmentation has also been observed as a result of oligomers formed by over-expression of a-syn in COS-7 cells [55].",
      "key": "d36c7095721245bac4ff55efe16dbf7a",
      "line": 179,
      "relation": "decreases",
      "source": 9,
      "target": 12
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " In contrast, a-syn 30–110 that forms fibrils at a fast rate, did not display toxicity, indicating that oligomers are indeed the toxic species leading to TH-neuron loss in vivo [162].",
      "key": "c05083c690153b838dce8d344a0ae5ac",
      "line": 83,
      "relation": "causesNoChange",
      "source": 8,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " a report by Hoffmann et al. showed that fibrillar a-syn induced a more pronounced inflammatory response in microglial cells [61].",
      "key": "790e0eea46574ba6d5003c315bb53e7a",
      "line": 125,
      "relation": "increases",
      "source": 8,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " a report by Hoffmann et al. showed that fibrillar a-syn induced a more pronounced inflammatory response in microglial cells [61].",
      "key": "95f57da35ef9ec7d105fa5dbc9615885",
      "line": 126,
      "relation": "increases",
      "source": 8,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " Finally, Parkinson’s disease patients carrying familial mutations in the parkin gene, and some of those with the LRRK2 G2019S mutation, show neuronal degeneration in the absence of Lewy body formation [28, 50]. ",
      "key": "b6b8d949642690275c160caec51d7273",
      "line": 70,
      "relation": "increases",
      "source": 32,
      "target": 46
    },
    {
      "key": "e5f918664f60ea8b97dd461ae588ef78",
      "relation": "hasVariant",
      "source": 31,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " Finally, Parkinson’s disease patients carrying familial mutations in the parkin gene, and some of those with the LRRK2 G2019S mutation, show neuronal degeneration in the absence of Lewy body formation [28, 50]. ",
      "key": "96aeb5838327f20d8ffbd825b7886d61",
      "line": 71,
      "relation": "increases",
      "source": 30,
      "target": 46
    },
    {
      "key": "edeae331d07a583676289065f5b2c0e0",
      "relation": "hasVariant",
      "source": 29,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " Interestingly, it was very recently reported that astrocytes take up a-syn oligomers and degrade it via the lysosomal pathway, but this pathway can become saturated leading to mitochondrial fragmentation [89]. ",
      "key": "4fe6b0c0208c4038076e430cb1bb929e",
      "line": 94,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 13,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "furthermore, treatment with salubrinal, which alleviates ER stress, reduced oligomeric accumulation in the ER.",
      "key": "69b4734d39703190c64da8b03e9c8c75",
      "line": 107,
      "relation": "decreases",
      "source": 4,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "furthermore, treatment with salubrinal, which alleviates ER stress, reduced oligomeric accumulation in the ER.",
      "key": "3b051099bcdbe011cff7825155a86166",
      "line": 109,
      "relation": "decreases",
      "source": 4,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Endoplasmic Reticulum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Finally, inhibition of histone deacetylase 6 (HDAC6), which was previously shown to be involved in the response to cytotoxic ubiquitinated aggregates, increased the oligomeric content in vitro, while overexpression of HDAC6 produced the opposite effect [36]. ",
      "key": "bbe1728fc9fdab550c39f21426a0650f",
      "line": 120,
      "relation": "decreases",
      "source": 28,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "a-syn accumulation has been linked to autophagic and lysosomal dysfunction, which may in turn lead to a-syn aggregation and production of more detrimental oligomers. ",
      "key": "34b4b30e2c8e0dd46c145103e25f2059",
      "line": 157,
      "relation": "increases",
      "source": 22,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Accordingly, overexpression of transcription factor EB (TFEB) was shown to correct lysosomal defects induced by the viral overexpression of a-syn and to downregulate the accumulation of oligomers in vivo [32]. ",
      "key": "30f449db77999107d7ce30ac036e09d2",
      "line": 162,
      "relation": "decreases",
      "source": 40,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " First, a-syn oligomers bind synaptobrevin, a component of the SNARE complex required for synaptic vesicle fusion, and prevent the formation of the SNARE complex [23]. ",
      "key": "720a53af90c220c68ddd1236dc80e673",
      "line": 167,
      "relation": "decreases",
      "source": 25,
      "target": 16
    },
    {
      "key": "7e5ddf2250f6d6c9ec5813a90f19f3da",
      "relation": "partOf",
      "source": 43,
      "target": 25
    },
    {
      "key": "1649093d61f8f9c802557e39f8b4a780",
      "relation": "partOf",
      "source": 10,
      "target": 26
    },
    {
      "key": "c0d4ba559e2448ad87e01a8351bb8146",
      "relation": "partOf",
      "source": 14,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "USP19 promoted the secretion of a-syn, suggesting that MAPS is an unconventional secretion pathway utilized by a-syn, particularly under conditions of proteasomal impairment, which has been repeatedly linked to Parkinson’s disease. ",
      "key": "5a3098cf5cf2f65d14b243354c3ac76e",
      "line": 184,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 42,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "key": "44b268d0f101661ec2afdf69eb1187a8",
      "line": 198,
      "relation": "decreases",
      "source": 3,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "key": "dc7b941bcec2b420d58ed5432b0775cd",
      "line": 199,
      "relation": "decreases",
      "source": 3,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": " In vitro studies have shown that curcumin inhibited the formation of fibrils and disaggregated amyloid-beta and a-syn [112, 114, 155].",
      "key": "ea7f18f50bea8e103064d9a9808b17d4",
      "line": 200,
      "relation": "decreases",
      "source": 3,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "key": "33cfbaedc0bdef04faf3ac0715269bb4",
      "line": 206,
      "relation": "decreases",
      "source": 0,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "key": "514cecf809208095cafaf2e795c6a154",
      "line": 207,
      "relation": "decreases",
      "source": 0,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Epigallocatechin-3-gallate (EGCG), a small molecule that been shown to inhibit the aggregation of several amyloidogenic proteins such as a-syn, amyloid-beta and huntingtin [9, 37, 38, 105] binds to unfolded native amyloid-beta and a-syn and promotes the formation of nontoxic oligomers that do not convert into amyloid fibrils [37]. ",
      "key": "8a9cdd4edefc359b26aacb3185db8881",
      "line": 208,
      "relation": "decreases",
      "source": 0,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Prabhudesai et al. showed that this molecule is able to inhibit the aggregation of a-syn in vitro and in a zebrafish model expressing human wild-type a-syn in neurons where CLR01 reduced apoptosis and improved embryo survival [127]. ",
      "key": "1b46df453aad4dbc228b2ff75c4a142f",
      "line": 213,
      "relation": "decreases",
      "source": 27,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true,
          "Cerebrospinal Fluid": true,
          "Serum": true
        }
      },
      "citation": {
        "authors": [
          "Alegre-Abarrategui J",
          "Bengoa-Vergniory N",
          "Roberts RF",
          "Wade-Martins R"
        ],
        "date": "2017-12-01",
        "db": "PubMed",
        "db_id": "28803412",
        "db_name": "Alpha-synuclein oligomers: a new hope.",
        "first": "Bengoa-Vergniory N",
        "journal": "Acta neuropathologica",
        "last": "Alegre-Abarrategui J",
        "pages": "819-838",
        "volume": "134"
      },
      "evidence": "Prabhudesai et al. showed that this molecule is able to inhibit the aggregation of a-syn in vitro and in a zebrafish model expressing human wild-type a-syn in neurons where CLR01 reduced apoptosis and improved embryo survival [127]. ",
      "key": "275b2720bcf567eaa0966ae5a79e3cfa",
      "line": 215,
      "relation": "decreases",
      "source": 27,
      "target": 17
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"(-)-epigallocatechin 3-gallate\")",
      "concept": {
        "name": "(-)-epigallocatechin 3-gallate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "3bb6ae0af6e42cc625143279db9d0952"
    },
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "concept": {
        "name": "calcium(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94df77a2db8d9014b42535235da90e5d"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "concept": {
        "name": "reactive oxygen species",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "39a67bec2ea8cb7a2bec39cf66e565ba"
    },
    {
      "bel": "a(CHEBI:curcumin)",
      "concept": {
        "name": "curcumin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "7af57558091f98bed6718820d043f953"
    },
    {
      "bel": "a(CHEBI:salubrinal)",
      "concept": {
        "name": "salubrinal",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "406f2235a7746eaca2dfbb6a86c293e5"
    },
    {
      "bel": "a(CONSO:CONSO00016)",
      "concept": {
        "name": "CONSO00016",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "9a854d08c85f1b40611d80bd7237eb60"
    },
    {
      "bel": "a(CONSO:CONSO00017)",
      "concept": {
        "name": "CONSO00017",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "44a0b1fe4217c6d0372523a46b90b3ca"
    },
    {
      "bel": "a(CONSO:CONSO00018)",
      "concept": {
        "name": "CONSO00018",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "34dd2f1fa683fcd7e9904d4b0d1682d6"
    },
    {
      "bel": "a(CONSO:CONSO00092)",
      "concept": {
        "name": "CONSO00092",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "3bae3abf28a7c53f14a76d39063a5f55"
    },
    {
      "bel": "a(CONSO:CONSO00093)",
      "concept": {
        "name": "CONSO00093",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "7e088128666c214ed4ec556d86d1f4b6"
    },
    {
      "bel": "a(GO:microtubule)",
      "concept": {
        "name": "microtubule",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "0fe6be9622e5650da7dca7cdced2f9db"
    },
    {
      "bel": "a(MESH:\"Cell Membrane\")",
      "concept": {
        "name": "Cell Membrane",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "5f1f124138addc7af92d1beca50bdbd4"
    },
    {
      "bel": "a(MESH:\"Golgi Apparatus\")",
      "concept": {
        "name": "Golgi Apparatus",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "1aafc8025e2a2fc2f3ae7e31828be07d"
    },
    {
      "bel": "a(MESH:Astrocytes)",
      "concept": {
        "name": "Astrocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f02fc0f5c8a1ab66a9a7d9130d56d6fe"
    },
    {
      "bel": "a(MESH:Kinesin)",
      "concept": {
        "name": "Kinesin",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a31f03dde42a4a94986145f81c34f994"
    },
    {
      "bel": "a(MESH:Mitochondria)",
      "concept": {
        "name": "Mitochondria",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "da073a8aacb1ab0764fce04ee8bbb54f"
    },
    {
      "bel": "bp(GO:\"SNARE complex assembly\")",
      "concept": {
        "name": "SNARE complex assembly",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "05b30e5bec54e53322cb72ef79a7b35f"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "concept": {
        "name": "apoptotic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9eb8739869ef0e82697f61a33d3d6afa"
    },
    {
      "bel": "bp(GO:\"axonal transport\")",
      "concept": {
        "name": "axonal transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c9d614fb05004498d4069f216f0458c8"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "concept": {
        "name": "microglial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3c02f523866973a040dc6bfa5b372b2e"
    },
    {
      "bel": "bp(GO:\"synaptic vesicle transport\")",
      "concept": {
        "name": "synaptic vesicle transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "dbdb5e01a1087a1e1cb7218e960573fc"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(MESH:\"Endoplasmic Reticulum Stress\")",
      "concept": {
        "name": "Endoplasmic Reticulum Stress",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "4f0b38d0eda6731c434a04e8489040f0"
    },
    {
      "bel": "complex(GO:\"proteasome complex\")",
      "concept": {
        "name": "proteasome complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "60eac9a2a13b2c4ebafe4ec275b444a2"
    },
    {
      "bel": "complex(a(CONSO:CONSO00093), p(HGNC:VAMP1))",
      "function": "Complex",
      "id": "221894b46d116205898461551dd9f74c",
      "members": [
        {
          "bel": "a(CONSO:CONSO00093)",
          "concept": {
            "name": "CONSO00093",
            "namespace": "CONSO"
          },
          "function": "Abundance",
          "id": "7e088128666c214ed4ec556d86d1f4b6"
        },
        {
          "bel": "p(HGNC:VAMP1)",
          "concept": {
            "name": "VAMP1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "99fd6c1525da5613719e5212d4e95481"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), a(MESH:Kinesin))",
      "function": "Complex",
      "id": "be3b854e6c6b9dcd375db01014817bd4",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "a(MESH:Kinesin)",
          "concept": {
            "name": "Kinesin",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "a31f03dde42a4a94986145f81c34f994"
        }
      ]
    },
    {
      "bel": "p(CONSO:CONSO00094)",
      "concept": {
        "name": "CONSO00094",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "36978d607179e37d84e40dac41ce60fe"
    },
    {
      "bel": "p(HGNC:HDAC6)",
      "concept": {
        "name": "HDAC6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8f10ead99d8970092c3980eb37bcfb3a"
    },
    {
      "bel": "p(HGNC:LRRK2)",
      "concept": {
        "name": "LRRK2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "94f9866a95fc9c4331b1a1958eb22b2d"
    },
    {
      "bel": "p(HGNC:LRRK2, var(\"p.Gly2019Ser\"))",
      "concept": {
        "name": "LRRK2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3b06f15a671328fe4fe9973d904c3672",
      "variants": [
        {
          "hgvs": "p.Gly2019Ser",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:PRKN)",
      "concept": {
        "name": "PRKN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e7cd420967c3dcd4f3a90b2e2a848002"
    },
    {
      "bel": "p(HGNC:PRKN, var(\"?\"))",
      "concept": {
        "name": "PRKN",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "464fa7a1977c13d0bbe95f4dca51e043",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA)",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8cd39bc202ad944395c27f63d95f6908"
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Ala30Pro\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "764f50e6254629d095d1ad048dfc679b",
      "variants": [
        {
          "hgvs": "p.Ala30Pro",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Ala53Glu\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b316af486a4fc0ee4d96d88e70f42b47",
      "variants": [
        {
          "hgvs": "p.Ala53Glu",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Ala53Thr\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "69feac4200a71d04c0038a26060abdee",
      "variants": [
        {
          "hgvs": "p.Ala53Thr",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Glu46Lys\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4f04a2fe9b0eb6c2316e89a61bc2c104",
      "variants": [
        {
          "hgvs": "p.Glu46Lys",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.Gly51Asp\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "aa800d2a2063a8d52ba9f78ac0391a5a",
      "variants": [
        {
          "hgvs": "p.Gly51Asp",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"p.His50Gln\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "317341b6ae7c2eccb918a8fec3054017",
      "variants": [
        {
          "hgvs": "p.His50Gln",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:TFEB)",
      "concept": {
        "name": "TFEB",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "92a32b69c6e6ffc968e227f1caed5786"
    },
    {
      "bel": "p(HGNC:TLR2)",
      "concept": {
        "name": "TLR2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "582bd46752f7f09b247672cebb3f0ea1"
    },
    {
      "bel": "p(HGNC:USP19)",
      "concept": {
        "name": "USP19",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0bcecf296b371541378d99d6ba51f640"
    },
    {
      "bel": "p(HGNC:VAMP1)",
      "concept": {
        "name": "VAMP1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "99fd6c1525da5613719e5212d4e95481"
    },
    {
      "bel": "path(CONSO:CONSO00037)",
      "concept": {
        "name": "CONSO00037",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "9a0d506ab659afd5ddbe1d8b7939104e"
    },
    {
      "bel": "path(MESH:\"Lewy Body Disease\")",
      "concept": {
        "name": "Lewy Body Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "a7168678b41ade6ae6c13573a8c9a4e6"
    },
    {
      "bel": "path(MESH:\"Neurodegenerative Diseases\")",
      "concept": {
        "name": "Neurodegenerative Diseases",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "c04acd23e7e69b92e4e4230d8551fcf4"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "concept": {
        "name": "Parkinson Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e45482025720b7db29c4fea458b4cae9"
    }
  ]
}